logo
China's Longer Bonds Fall on Bets Mega Dam May Support Economy

China's Longer Bonds Fall on Bets Mega Dam May Support Economy

Bloomberg21-07-2025
China's longer tenor government bonds fell amid waning demand for haven assets as investors saw the launch of a 1.2 trillion yuan ($167 billion) mega-dam project in Tibet providing more support to the economy.
Futures on China's 30-year government bonds fell as much as 0.5% on Monday to hit the lowest in six weeks, while some of the nation's power and construction stocks jumped. The launch of the hydropower plant which is estimated to cost more than four times that for Three Gorges — world's largest power project — promises an economic jolt for sectors like construction, cement and steel and boost the economy.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Should You Buy Pfizer (PFE) Stock Before August 5? Here's What History Says
Should You Buy Pfizer (PFE) Stock Before August 5? Here's What History Says

Yahoo

time21 minutes ago

  • Yahoo

Should You Buy Pfizer (PFE) Stock Before August 5? Here's What History Says

Key Points Pfizer has beaten its earnings per share (EPS) estimates in its past 12 quarters. Beating EPS estimates hasn't always meant positive movements for Pfizer's share price. The stock's low valuation and ultra-high dividend make it a good choice for long-term investors. 10 stocks we like better than Pfizer › Pfizer (NYSE: PFE) has been around for over 175 years, but it became a true household name during the COVID-19 pandemic as one of the main vaccine suppliers. That led to its stock price and revenue skyrocketing, and even brought Pfizer's market cap to over $340 billion at one point. Since its late-2021 peak, Pfizer's stock is down over 60%. In the past three years, it's off by 52%, even while beating its earnings per share (EPS) estimates in all 12 reported earnings in that time. Pfizer will report its fiscal second-quarter earnings on Aug. 5. Although we won't know if it'll continue its beats streak until then, it's probably not a good idea to try to time your investment around the date. Let's take a look at why. There's no correlation between Pfizer's earnings and immediate stock price moves You would think that a company beating its earnings estimates would excite investors and lead to positive stock price movements, but that's unfortunately not how the stock market operates. Other factors influence stock price movements -- such as future guidance, the macroeconomic environment, and overall investor sentiment -- so focusing on earnings alone can misguide you. Even with Pfizer's consistency in beating earnings estimates, history has shown that this hasn't always sent its stock price up. The table below shows its next-day stock price movements after earnings reporting. Reported Quarter Beat EPS Estimates? Positive Next-Day Stock Price Move May 2025 Yes Yes Feb. 2025 Yes No Oct. 2024 Yes No July 2024 Yes Yes May 2024 Yes Yes Jan. 2024 Yes No Aug. 2023 Yes No May 2023 Yes No Data sources: AlphaQuery and YCharts. Regardless of the company, it's helpful to remember this: It's never a good idea to try to time the market, because the market doesn't behave rationally -- at least, in the short term. Pfizer is a good value opportunity If you're looking for reasons to invest in Pfizer, they shouldn't revolve around its upcoming earnings date. Instead, invest because of its cheap valuation and ultra-high dividend yield. Pfizer is currently trading at 8 times its forward earnings, which is less than competitors like Johnson & Johnson, AbbVie, and Eli Lilly, and far below the S&P 500 healthcare sector's 16.5 average. Pfizer's stock has lagged behind the overall market, but this low valuation gives it more long-term upside than downside, in my opinion. We can't predict how its stock will perform in the near-term, but its 7% dividend yield (as of July 29) is a great incentive to keep investors patient. If you're in on Pfizer for the long term, now seems like a good opportunity to begin a stake (or increase your current shares). But if you're looking to make some quick cash from a potential post-earnings swing, you're essentially gambling. Should you invest $1,000 in Pfizer right now? Before you buy stock in Pfizer, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Pfizer wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $638,629!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,098,838!* Now, it's worth noting Stock Advisor's total average return is 1,049% — a market-crushing outperformance compared to 182% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025 Stefon Walters has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends AbbVie and Pfizer. The Motley Fool recommends Johnson & Johnson. The Motley Fool has a disclosure policy. Should You Buy Pfizer (PFE) Stock Before August 5? Here's What History Says was originally published by The Motley Fool Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data

Pakistan and US reach a trade agreement to develop oil reserves and reduce tariffs
Pakistan and US reach a trade agreement to develop oil reserves and reduce tariffs

Chicago Tribune

time22 minutes ago

  • Chicago Tribune

Pakistan and US reach a trade agreement to develop oil reserves and reduce tariffs

ISLAMABAD — The United States and Pakistan reached a trade agreement expected to allow Washington to help develop Pakistan's largely untapped oil reserves and lower tariffs for the South Asian country, officials from both nations said Thursday. Officials did not specify where the exploration would take place, but most of Pakistan's reserves are believed to be in the insurgency-hit southwestern province of Balochistan, where separatists say the province's natural resources are being exploited by the central government in Islamabad. 'We have just concluded a deal with the country of Pakistan, whereby Pakistan and the United States will work together on developing their massive oil reserves,' U.S. President Donald Trump wrote on his Truth Social platform. 'We are in the process of choosing the oil company that will lead this partnership,' Trump added. 'Who knows, maybe they'll be selling oil to India someday!' Total U.S. trade with Pakistan was an estimated $7.3 billion in 2024, according to the Office of the United States Representative, which said on its website that U.S. exports to Pakistan in 2024 were $2.1 billion, up 4.4% ($90.9 million) from 2023. U.S. imports from Pakistan totaled $5.1 billion in 2024, up 4.9% ($238.7 million) from 2023, it said. There was no immediate comment from the Baloch nationalists and separatist groups. Balochistan has long been the center of violence mostly blamed on groups including the outlawed Balochistan Liberation Army, or BLA, which the U.S. designated a terrorist organization in 2019. Separatists in Balochistan have opposed the extraction of resources by Pakistani and foreign firms and have targeted Pakistani security forces and Chinese nationals working on multibillion-dollar projects related to the China-Pakistan Economic Corridor. Oil reserves are also thought to exist in the southern Sindh, eastern Punjab and northwestern Khyber Pakhtunkhwa provinces. Pakistan's Prime Minister Shehbaz Sharif welcomed the 'long-awaited' deal and thanked Trump for playing a key role in finalizing it. Pakistan had been pursuing a trade agreement since May, when Trump mediated a ceasefire between Pakistan and India following an escalation triggered by Indian airstrikes on Pakistani territory in response to the killing of 26 tourists in Indian-controlled Kashmir. Pakistan's Finance Ministry said in a statement early Thursday the agreement aims to boost bilateral trade, expand market access, attract investment and foster cooperation in areas of mutual interest. The breakthrough came during a meeting in Washington between Pakistani Finance Minister Muhammad Aurangzeb and senior U.S. officials, including Commerce Secretary Howard Lutnick and Trade Representative Ambassador Jamieson Greer. The deal includes a reduction in reciprocal tariffs, particularly on Pakistani exports to the U.S., the statement from the ministry said. 'The agreement enhances Pakistan's access to the U.S. market and vice versa,' it said. The agreement is also expected to spur increased U.S. investment in Pakistan's infrastructure and development projects, it added. The ministry said the deal reflects both nations' commitment to deepening bilateral ties and strengthening trade and investment cooperation.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store